SEARCH

SEARCH BY CITATION

References

  • 1
    Today in Science History. Website. Available at http://www.todayinsci.com/H/Hodgkin_Dorothy/HodgkinDorothy-Quotations.htm Last accessed 19 November 2010.
  • 2
    Feero WG, Guttmacher AE, Collins FS. Genomic medicine – an updated primer. N Engl J Med 2010; 362: 20012011.
  • 3
    Gloyn AL, Pearson ER, Antcliff JF, Proks P, Bruining GJ, Slingerland AS et al. Activating mutations in the gene encoding the ATP-sensitive potassium-channel subunit Kir6.2 and permanent neonatal diabetes. N Engl J Med 2004; 350: 18381849.
  • 4
    Pearson ER, Flechtner I, Njølstad PR, Malecki MT, Flanagan SB, Larkin B et al. Switching from insulin to oral sulfonylureas in patients with diabetes due to Kir6.2 mutations. N Engl J Med 2006; 355: 467477.
  • 5
    Ellard S, Bellanne-Chantelot C, Hattersley AT. Best practice guidelines for the molecular genetic diagnosis of maturity-onset diabetes of the young. Diabetologia 2008; 51: 546553.
  • 6
    Stumvoll M, Goldstein BJ, van Haeften TW. Type 2 diabetes: principles of pathogenesis and therapy. Lancet 2005; 365: 13331346.
  • 7
    Hattersley AT, McCarthy MI. A question of standards: what makes a good genetic association study? Lancet 2005; 366: 13151323.
  • 8
    Altshuler D, Hirschhorn JN, Klannemark M, Lindgren CM, Vohl C-M, Nemesh J et al. The common PPARγ Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes. Nat Genet 2000; 26: 7680.
  • 9
    Gloyn AL, Weedon MN, Owen KR, Turner MJ, Knight BA, Hitman GA et al. Large-scale association studies of variants in genes encoding the pancreatic beta-cell K-ATP channel subunits Kir6.2 (KCNJ11) and SUR1 (ABCC8) confirm that the KCNJ11 E23K variant is associated with increased risk of type 2 diabetes. Diabetes 2003; 52: 568572.
  • 10
    International HapMap Consortium. A haplotype map of the human genome. Nature 2005; 437: 12991320.
  • 11
    Wellcome Trust Case Control Consortium. Genome-wide association study of 14 000 cases of seven common diseases and 3000 shared controls. Nature 2007; 447: 661678.
  • 12
    McCarthy MI, Abecasis GR, Cardon LR, Little J, Ioannidis JPA, Goldstein DB et al. Genome-wide association studies for complex traits: consensus, uncertainty and challenges. Nat Rev Genet 2008; 9: 356369.
  • 13
    Sladek R, Rocheleau G, Rung J, Dina C, Shen L, Serre D et al. A genome-wide association study identifies novel risk loci for type 2 diabetes. Nature 2007; 445: 828830.
  • 14
    Frayling TM, Timpson NJ, Weedon MN, Zeggini E, Freathy RM, Lindgren CM et al. A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity. Science 2007; 316: 889894.
  • 15
    Zeggini E, Weedon MN, Lindgren CM, Frayling TM, Elliott KS, Lango H et al. Replication of genome-wide association signals in UK samples reveals risk loci for type 2 diabetes. Science 2007; 316: 13361341.
  • 16
    Scott LJ, Mohlke KL, Bonnycastle LL, Willer CJ, Li Y, Duren WL et al. A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants. Science 2007; 316: 13411345.
  • 17
    Diabetes Genetics Initiative of Broad Institute of Harvard and MIT, Lund University, and Novartis Institutes of BioMedical Research. Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels. Science 2007; 316: 13311336.
  • 18
    Steinthorsdottir V, Thorleifsson G, Reynisdottir I, Benediktsson R, Jonsdottir T, Walters BG et al. A variant in CDKAL1 influences insulin response and risk of type 2 diabetes. Nat Genet 2007; 39: 770775.
  • 19
    Zeggini E, Scott LJ, Saxena R, Voight BF, Marchini JL, Hu T et al. Meta-analysis of genome-wide association data and large-scale replication identifies additional susceptibility loci for type 2 diabetes. Nat Genet 2008; 40: 638645.
  • 20
    Yasuda K, Miyake K, Horikawa Y, Hara K, Osawa H, Furuta H et al. Variants in KCNQ1 are associated with susceptibility to type 2 diabetes mellitus. Nat Genet 2008; 40: 10921097.
  • 21
    Unoki H, Takahashi A, Kawaguchi T, Hara K, Horikoshi M, Andersen G et al. SNPs in KCNQ1 are associated with susceptibility to type 2 diabetes in East Asian and European populations. Nat Genet 2008; 40: 10981102.
  • 22
    Prokopenko I, Langenberg C, Florez JC, Saxena R, Soranzo N, Thorleifsson G et al. Variants in the melatonin receptor 1B gene (MTNR1B) influence fasting glucose levels. Nat Genet 2009; 41: 7781.
  • 23
    Lyssenko V, Nagorny CL, Erdos MR, Wierup N, Jonsson A, Spegel P et al. Common variant in MTNR1B associated with increased risk of type 2 diabetes and impaired early insulin secretion. Nat Genet 2009; 41: 8288.
  • 24
    Bouatia-Naji N, Bonnefond A, Cavalcanti-Proenca C, Sparso T, Holmkvist J, Marchand M et al. A variant near MTNR1B is associated with increased fasting plasma glucose levels and type 2 diabetes risk. Nat Genet 2009; 41: 8994.
  • 25
    Rung J, Cauchi S, Albrechtsen A, Shen L, Rocheleau G, Cavalcanti-Proenca C et al. Genetic variant near IRS1 is associated with type 2 diabetes, insulin resistance and hyperinsulinemia. Nat Genet 2009; 41: 11101115.
  • 26
    Dupuis J, Langenberg C, Prokopenko I, Saxena R, Soranzo N, Jackson AU et al. New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk. Nat Genet 2010; 42: 105116.
  • 27
    Voight BF, Scott LJ, Steinthorsdottir V, Morris AP, Dina C, Welch RP et al. Twelve type 2 diabetes susceptibility loci identified through large-scale association analysis. Nat Genet 2010; 42: 579589.
  • 28
    Tsai F-J, Yang C-F, Chen C-C, Chuang L-M, Lu C-H, Chang C-T et al. A genome-wide association study identifies susceptibility variants for type 2 diabetes in Han Chinese. PLoS Genet 2010; 6: e1000847.
  • 29
    Qi L, Cornelis MC, Kraft P, Stanya KJ, Kao WHL, Pankow JS et al. Genetic variants at 2q24 are associated with susceptibility to type 2 diabetes. Hum Mol Genet 2010; 19: 27062715.
  • 30
    Yamauchi T, Hara K, Maeda S, Yasuda K, Takahashi A, Horikoshi M et al. A genome-wide association study in the Japanese population identifies susceptibility loci for type 2 diabetes at UBE2E2 and C2CD4A/C2CD4B. Nat Genet 2010; 42: 864868.
  • 31
    Frayling TM. Genome-wide association studies provide new insights into type 2 diabetes aetiology. Nat Rev Genet 2007; 8: 657662.
  • 32
    DeBaun MR, Niemitz EL, McNeil DE, Brandenburg SA, Lee MP, Feinberg AP. Epigenetic alterations of H19 and LIT1 distinguish patients with Beckwith–Wiedemann Syndrome with cancer and birth defects. Am J Hum Genet 2002; 70: 604611.
  • 33
    Kassem SA, Ariel I, Thornton PS, Hussain K, Smith V, Lindley KJ et al. p57(KIP2) expression in normal islet cells and in hyperinsulinism of infancy. Diabetes 2001; 50: 27632769.
  • 34
    Kong A, Steinthorsdottir V, Masson G, Thorleifsson G, Sulem P, Besenbacher S et al. Parental origin of sequence variants associated with complex diseases. Nature 2009; 462: 868874.
  • 35
    Florez JC. Newly identified loci highlight beta-cell dysfunction as a key cause of type 2 diabetes: where are the insulin resistance genes? Diabetologia 2008; 51: 11001110.
  • 36
    Freathy RM, Timpson NJ, Lawlor DA, Pouta A, Ben-Shlomo Y, Ruokonen A et al. Common variation in the FTO gene alters diabetes-related metabolic traits to the extent expected, given its effect on BMI. Diabetes 2008; 57: 14191426.
  • 37
    Helgadottir A, Thorleifsson G, Magnusson KP, Gretarsdottir S, Steinthorsdottir V, Manolescu A et al. The same sequence variant on 9p21 associates with myocardial infarction, abdominal aortic aneurysm and intracranial aneurysm. Nat Genet 2008; 40: 217224.
  • 38
    Krishnamurthy J, Ramsey MR, Ligon KL, Torrice C, Koh A, Bonner-Weir S et al. p16INK4a induces an age-dependent decline in islet regenerative potential. Nature 2006; 443: 453457.
  • 39
    Pasmant E, Laurendeau I, Heron D, Vidaud M, Vidaud D, Bieche I. Characterization of a germ-line deletion, including the entire INK4/ARF locus, in a melanoma-neural system tumor family: identification of ANRIL, an antisense non-coding RNA whose expression co-clusters with ARF. Cancer Res 2007; 67: 39633969.
  • 40
    Gudmundsson J, Sulem P, Steinthorsdottir V, Bergthorsson JT, Thorleifsson G, Manolescu A et al. Two variants on chromosome 17 confer prostate cancer risk, and the one in TCF2 protects against type 2 diabetes. Nat Genet 2007; 39: 977983.
  • 41
    Hales CN, Barker DJP. Type 2 (non-insulin-dependent) diabetes mellitus: the thrifty phenotype hypothesis. Diabetologia 1992; 35: 595601.
  • 42
    Dabelea D, Pettitt DJ. Intrauterine diabetic environment confers risks for type 2 diabetes mellitus and obesity in the offspring, in addition to genetic susceptibility. J Pediatr Endocrinol Metab 2001; 14: 10851091.
  • 43
    Hattersley AT, Tooke JE. The fetal insulin hypothesis: an alternative explanation of the association of low birthweight with diabetes and vascular disease. Lancet 1999; 353: 17891792.
  • 44
    Hattersley AT, Beards F, Ballantyne E, Appleton M, Harvey R, Ellard S. Mutations in the glucokinase gene of the fetus result in reduced birth weight. Nat Genet 1998; 19: 268270.
  • 45
    Freathy RM, Mook-Kanamori DO, Sovio U, Prokokenko I, Timpson NJ, Berry DJ et al. Variants at two loci (in ADCY5 and near CCNL1) influence fetal growth and birth weight. Nat Genet 2010; 42: 430435.
  • 46
    Freathy RM, Bennett AJ, Ring SM, Shields B, Groves CJ, Timpson NJ et al. Type 2 diabetes risk alleles are associated with reduced size at birth. Diabetes 2009; 58: 14281433.
  • 47
    Freathy RM, Weedon MN, Bennett A, Hypponen E, Relton CL, Knight B et al. Type 2 diabetes TCF7L2 risk genotypes alter birth weight: a study of 24 053 individuals. Am J Hum Genet 2007; 80: 11501161.
  • 48
    Lango H, The UK Type 2 Diabetes Genetics Consortium, Palmer CNA, Morris AD, Zeggini E, Hattersley AT et al. Assessing the combined impact of 18 common genetic variants of modest effect sizes on type 2 diabetes risk. Diabetes 2008; 57: 31293135.
  • 49
    Manolio TA, Collins FS, Cox NJ, Goldstein DB, Hindorff LA, Hunter DJ et al. Finding the missing heritability of complex diseases. Nature 2009; 461: 747753.
  • 50
    Gaulton KJ, Nammo T, Pasquali L, Simon JM, Giresi PG, Fogarty MP et al. A map of open chromatin in human pancreatic islets. Nat Genet 2010; 42: 255259.